Insulet Corp Files 8-K/A Amendment

Ticker: PODD · Form: 8-K/A · Filed: 2025-04-09T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, amendment, officer-changes, director-changes

Related Tickers: PODD

TL;DR

Insulet Corp filed an 8-K/A amendment on March 14, 2025, updating exec/director info and adding exhibits.

AI Summary

Insulet Corporation filed an amendment (8-K/A) on April 9, 2025, to its previous report dated March 14, 2025. This amendment pertains to the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. The filing also includes financial statements and exhibits.

Why It Matters

This amendment provides updated information regarding executive and director changes, which can impact corporate governance and strategic direction.

Risk Assessment

Risk Level: low — This is an amendment to a previous filing, primarily providing updated information on corporate governance and financial statements, with no immediate indication of significant new risks.

Key Numbers

Key Players & Entities

FAQ

What specific officer or director changes are detailed in this 8-K/A filing?

The filing indicates updates related to the departure of directors or certain officers, election of directors, and appointment of certain officers, as well as compensatory arrangements for certain officers.

What is the primary purpose of this 8-K/A filing?

This is an amendment to a previous 8-K filing, providing updated information on corporate governance matters and including financial statements and exhibits.

On what date was the earliest event reported in this amendment?

The earliest event reported was on March 14, 2025.

What is Insulet Corporation's principal executive office address?

The principal executive office is located at 100 Nagog Park Acton Massachusetts 01720.

Does this filing include any new financial statements?

Yes, the filing explicitly states that it includes 'Financial Statements and Exhibits'.

From the Filing

0001145197-25-000016.txt : 20250409 0001145197-25-000016.hdr.sgml : 20250409 20250409160845 ACCESSION NUMBER: 0001145197-25-000016 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250314 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250409 DATE AS OF CHANGE: 20250409 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INSULET CORP CENTRAL INDEX KEY: 0001145197 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 043523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-33462 FILM NUMBER: 25825275 BUSINESS ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: 978-600-7000 MAIL ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 8-K/A 1 podd-20250314.htm 8-K/A podd-20250314 0001145197 FALSE 0001145197 2025-03-14 2025-03-14 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K/A (Amendment No. 1)   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported):  March 14, 2025   INSULET CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-33462 04-3523891 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 100 Nagog Park Acton Massachusetts 01720 (Address of Principal Executive Offices, including Zip Code) Registrant’s telephone number, including area code: (978) 600-7000 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter) Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐ Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.001 Par Value Per Share PODD The NASDAQ Stock Market, LLC Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. This Amendment No. 1 on Form 8-K/A (this “ Amendment ”) is being filed by Insulet Corporation (the “ Company ”), to amend and supplement its Current Report on Form 8-K filed with the Securities and Exchange Commission on March 17, 2025 (the “ Original Report ”). As previously disclosed in the Original Report, Mark Field, who had been serving as the Company’s Senior Vice President and Chief Technology Officer, left the Company, effective March 14, 2025. On April 7, 2025, the Company and Mr. Field entered into a Consulting Services Agreement

View on Read The Filing